Home | Welcome to Contract Pharma   
Last Updated Wednesday, July 23 2014
Print RSS Feed

Breaking News

Related Searches:
January 12, 2011
An affiliate of Sun European Partners, LLP has entered into an agreement to acquire NextPharma Technologies Holding Ltd., a global provider of contract manufacturing, product development, clinical trials and logistics services to the pharmaceutical and bi  Read More »
January 12, 2011
Xcellerex, Inc. has received the Invensys Operations Management OPEN award for “innovative use of Invensys products and solutions to generate considerable business results” in four Operational Excellence categories.  Read More »
January 12, 2011
Tracey Burr, Ph.D., has been appointed chief technology officer for PharmaZell GmbH.   Read More »
January 11, 2011
Eli Lilly and Co. and Boehringer Ingelheim entered a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development.  Read More »
January 11, 2011
Elite Pharmaceuticals, Inc. and Hi-Tech Pharmacal Co., Inc. have entered into an agreement under which Elite will develop an intermediate for Hi-Tech for a generic version of a prescription product.  Read More »
January 11, 2011
PPD, Inc. has established a joint venture with Taijitu Biologics Ltd. (TBL), named BioDuro Biologics, to discover novel biotherapeutics.   Read More »
January 11, 2011
DSM BioSolutions, Royal DSM's microbial fermentation contract manufacturing business, and BiAqua B.V., a bio-based solutions provider for serious water contamination issues, have entered into an agreement for strain development, process development and pr  Read More »
January 11, 2011
Ray Dawkins, M.D., has been appointed chief medical officer at Camargo Pharmaceutical Services.  Read More »
January 11, 2011
Galapagos NV has completed first-in-human trials with GLPG0555 in healthy volunteers in its arthritis alliance with GlaxoSmithKline.   Read More »
January 10, 2011
AMT has entered into an agreement with Institut Pasteur, and a group of French research institutes (the "Consortium"), to support clinical development of a gene therapy to treat Sanfilippo B.  Read More »
January 10, 2011
novel small molecule therapeutics targeting histone methyltransferases (HMTs), an important class of epigenetic enzymes, for the treatment of cancer and other diseases.  Read More »
January 10, 2011
Bristol-Myers Squibb and Pharmasset have entered into a clinical collaboration agreement to evaluate BMS-790052, a NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset’s nucleotide polymerase inhibitor for the treatment of ch  Read More »
January 7, 2011
Savient Pharmaceuticals provided an update on its business activities related to the U.S. launch and commercialization of Krystexxa, a PEGylated uric acid specific enzyme for the treatment of chronic gout.  Read More »
January 7, 2011
Cambrex Zenara is supplying product for Johnson & Johnson Ltd.'s launch of smoking cessation drug Nicorette in India.  Read More »
January 7, 2011
Effie Toshav, J.D., has been appointed senior vice president and general counsel at AVI BioPharma, effective January 10th.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On